Participants to the International Liver Congress™ 2012 (ILC) are invited to submit abstracts on the categories listed below. All accepted abstracts will be published in the Journal of Hepatology and if selected, either the principal author or someone from his/her group will be requested to present the abstract.
Abstracts presented at previous international gastroenterology or hepatology meetings are NOT accepted.
Note: After submission, all abstracts are viewed anonymously by experts and are scored according to their merit. Thereafter, abstracts are selected for oral or poster presentations by the Scientific Committee of the EASL Governing Board.
For rules and guidelines for submission, please click here.
| Late breaking abstracts deadline: February 20 - 27, 2012 |
Abstract Categories for ILC 2012
| 1. Liver transplantation / surgery: | a. Experimental |
| b. Clinical | |
| c. Acute liver failure – clinical & experimental | |
| 2. Cirrhosis and its complications: | a. Pathophysiology |
| b. Clinical aspects | |
| c. Bleeding | |
| d. Hepatorinal syndrome and ascites | |
| 3. Liver Tumours: | a. Experimental |
| b. Clinical (epidemiology, diagnosis) | |
| c. Management | |
| 4. Molecular and cellular biology: | a. Cell cycle control / apoptosis |
| b. Biliary tract pathophysiology | |
| c. HSCs and fibrosis | |
| d. Liver regeneration | |
| 5. Liver Immunology including Viral Hepatitis | |
| 6. Non-invasive markers of liver fibrosis | |
| 7. Viral Hepatitis B & D: | a. Experimental |
| b. Clinical (except therapy) | |
| c. Clinical (therapy, new compounds, resistance) | |
| 8. Viral Hepatitis C: | a. Experimental (virology) |
| b. Clinical (except therapy) | |
| c. Clinical (therapy) | |
| d. Clinical (new compounds, resistance) | |
| 9. Viral Hepatitis A and E | |
| 10. Fatty Liver Disease: | a. Experimental |
| b. Clinical | |
| 11. Alcoholic liver disease and drug induced liver disease | |
| 12. Autoimmune and chronic cholestatic liver diseases | |
| 13. Genetic and pediatric liver diseases | |
| 14. EU Public Health | |
| * Special category: IASL Global Health | |
